Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye Lin

Showing results (751-760 of 756) with videos related to

Pageof 76
Sort By:
You have reached the last page of results.This site can display upto 756 results.
Microbiome|May 17, 2025
Tissue-resident microbiota signature in nasopharyngeal carcinomaXi-Rong Tan, Han Qiao, Ying-Qing Li, et al.
Clinical Oral Implants Research|February 24, 2026
Consensus Report of Group 2 of the 1st Global Consensus for Clinical Guidelines for the Rehabilitation of the Edentulous Maxilla: Zygomatic, Standard-Length, and Short Implant-Supported ProsthesesKevser Pala, Jörg Neugebauer, Daniel Buser, et al.
Journal of the National Cancer Institute|October 23, 2020
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaYuan Lei, Ying-Qin Li, Wei Jiang, et al.
Lancet (London, England)|June 2, 2024
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialXu Liu, Yuan Zhang, Kun-Yu Yang, et al.
JAMA|March 13, 2025
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical TrialYe-Lin Liang, Xu Liu, Liang-Fang Shen, et al.
JAMA|August 21, 2025
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial, Cheng Xu, Xiao-Yu Liang, et al.
Pageof 76

Showing results (751-760 of 756) with videos related to

Sort By:
Pageof 76
You have reached the last page of results.This site can display upto 756 results.
Microbiome|May 17, 2025
Tissue-resident microbiota signature in nasopharyngeal carcinomaXi-Rong Tan, Han Qiao, Ying-Qing Li, et al.
Clinical Oral Implants Research|February 24, 2026
Consensus Report of Group 2 of the 1st Global Consensus for Clinical Guidelines for the Rehabilitation of the Edentulous Maxilla: Zygomatic, Standard-Length, and Short Implant-Supported ProsthesesKevser Pala, Jörg Neugebauer, Daniel Buser, et al.
Journal of the National Cancer Institute|October 23, 2020
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaYuan Lei, Ying-Qin Li, Wei Jiang, et al.
Lancet (London, England)|June 2, 2024
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialXu Liu, Yuan Zhang, Kun-Yu Yang, et al.
JAMA|March 13, 2025
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical TrialYe-Lin Liang, Xu Liu, Liang-Fang Shen, et al.
JAMA|August 21, 2025
Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial, Cheng Xu, Xiao-Yu Liang, et al.
Pageof 76